Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Smart Quote
Windlas Biotech Ltd.
BSE Code 543329
ISIN Demat INE0H5O01029
Book Value (Rs) 207.54
NSE Code WINDLAS
Dividend Yield % 0.73
Market Cap(Rs Mn) 11446.50
TTM PE(x) 21.74
TTM EPS(Rs) 25.31
Face Value (Rs) 5  
 
May 18, 2024
Last Price  550.35  
Prev.Close  542.80  
Net Change  7.55  
52-Week High  590.00  
Open  550.00  
High  560.95  
Low   543.55
52-Week Low  260.00  
 
1 D | 1 M | 3 M | 1 Y
Stock Return Performance (in %) M Cap Sales
  Company Name 1W 1M 6M 1Y
Windlas Biotech   7   6   26   102
Sun Pharma Inds.   0   1   29   65
Cipla   -1   4   13   54
Zydus Lifesciences   11   18   74   118
Divi's Lab   0   6   7   24
BSE HC   2   3   21   56
 Company Name 1W 1M 6M 1Y
Windlas Biotech   7   6   26   102
Sun Pharma Inds.   0   1   29   65
Dr. Reddy's Lab   -2   -2   4   32
Cipla   -1   4   13   54
Aurobindo Pharma   2   8   20   101
BSE HC   2   3   21   56
Sensex   2   2   13   20
 
News
More
Key Maket Ratio
Latest EPS 25.31 MktCap/Sales 1.91
Latest CEPS 32   P/CEPS 17
Price / BV 2.65 Price / Sales 0.09
EV / EBIDTA 13.33 EV / Sales 1.86
Div Yield % 0.73    
Results Standalone Consolidated
TTM Latest 4 Quarters Quarter on Quarter
Particulars Prev.TTM
Net Sales  4945 
PBDIT 581 
PAT 464 
EPS 22 
Dec 2023Sep 2023Jun 2023Mar 2023
1622152714481407
203187171164
151140121114
7765
Dec 2022  Var %
1197  36 
139  46 
92  64 
71 
TTM Latest 4 Quarters Quarter on Quarter
Particulars Prev.TTM
Net Sales  4945 
PBDIT 576 
PAT 460 
EPS 21 
Dec 2023Sep 2023Jun 2023Mar 2023
1622152714481407
203187171164
151140121114
7765
Dec 2022  Var %
1197  36 
139  46 
92  64 
72 
MF Holding Details
 
Competitors
 Peer CompaniesLTP%Chg
Abbott India 26643.7 0.58
Pfizer 4473.85 1.59
Glaxosmithkline Phar 2355.75 2.8
Concord Biotech 1494.85 4.43
Zydus Lifesciences 1104.45 5